Commentary: fibroblast growth factor 19 in patients with bile acid diarrhoea

被引：1
|
作者：
Camilleri, M. [1 ]
Acosta, A. [1 ]
机构：
[1] Mayo Clin, CENTER, Rochester, MN 55905 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 38卷 / 10期
关键词：
IRRITABLE-BOWEL-SYNDROME; MALABSORPTION;
D O I：
10.1111/apt.12487
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1320 / 1321
页数：2
相关论文
共 50 条
  • [31] The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
    Aditi Kumar
    Niall Galbraith
    Hafid O. Al-Hassi
    Manushri Jain
    Oliver Phipps
    Jeffrey Butterworth
    Helen Steed
    John McLaughlin
    Matthew J. Brookes
    BMC Gastroenterology, 22
  • [32] The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
    Kumar, Aditi
    Galbraith, Niall
    Al-Hassi, Hafid O.
    Jain, Manushri
    Phipps, Oliver
    Butterworth, Jeffrey
    Steed, Helen
    McLaughlin, John
    Brookes, Matthew J.
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [33] Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
    Inagaki, T
    Choi, M
    Moschetta, A
    Peng, L
    Cummins, CL
    McDonald, JG
    Luo, G
    Jones, SA
    Goodwin, B
    Richardson, JA
    Gerard, RD
    Repa, JJ
    Mangelsdorf, DJ
    Kliewer, SA
    CELL METABOLISM, 2005, 2 (04) : 217 - 225
  • [34] High Expression of the Bile Salt-Homeostatic Hormone Fibroblast Growth Factor 19 in the Liver of Patients with Extrahepatic Cholestasis
    Schaap, Frank G.
    van der Gaag, Niels A.
    Gouma, Dirk J.
    Jansen, Peter L. M.
    HEPATOLOGY, 2009, 49 (04) : 1228 - 1235
  • [35] Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals
    Renner, Olga
    Harsch, Simone
    Matysik, Silke
    Luetjohann, Dieter
    Schmitz, Gerd
    Stange, Eduard F.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2014, 2 (03) : 216 - 225
  • [36] Evaluation of Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-One in the Diagnosis of Bile Acid Diarrhea
    Pattni, Sanjeev S.
    Brydon, Gordon
    Dew, Tracy
    Walters, Julian R.
    GASTROENTEROLOGY, 2010, 138 (05) : S107 - S107
  • [37] Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
    Lundasen, T.
    Galman, C.
    Angelin, B.
    Rudling, M.
    JOURNAL OF INTERNAL MEDICINE, 2006, 260 (06) : 530 - 536
  • [38] DIAGNOSTIC ACCURACY AND PREDICTIVE VALUE OF SERUM FIBROBLAST GROWTH FACTOR 19 (FGF19) AND TOTAL FREE FECAL BILE ACIDS AS BIOMARKERS OF BILE ACID MALABSORPTION IN PATIENTS WITH CHRONIC DIARRHEA: A PILOT STUDY
    Lyutakov, Ivan
    Nakov, Radislav
    Vladimirov, Borislav
    Nakov, Ventsislav
    Dimov, Anastas
    Asenova, Boyana
    Chetirska, Milena
    Vatcheva-Dobrevska, Rositsa
    Kyoseva, Duyana
    Terzieva, Nedelina
    Penchev, Plamen
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2020, 73 (12): : 1751 - 1758
  • [39] Diagnostics for bile acid diarrhoea
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (12): : 1077 - 1077
  • [40] Lower expression of bile acid transporters and fibroblast growth factor 19 in mucosa biopsies from the intestine of patients with type 2 diabetes compared to healthy controls
    Nerild, H. H.
    El Haddouchi, A.
    Bronden, A.
    Jorsal, T.
    Sonne, D. P.
    Jelsing, J.
    Rigbolt, K.
    Vilsboll, T.
    Knop, F. K.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S156 - S156
12345